[Antimetabolites in the therapy of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. I].
D000630:Aminopterin / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology / Q000627:therapeutic use*; D001375:Azaguanine / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism; D015122:Mercaptopurine / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000963:Antimetabolites; D004273:DNA, Neoplasm; D011687:Purines; D011799:Quinazolines; D012334:RNA, Neoplasm; D003561:Cytarabine; D015122:Mercaptopurine; D000630:Aminopterin; D001375:Azaguanine
Gli antimetaboliti nella terapia delle leucosi acute umane. Meccanismo d'azione e fattori condizionanti la risposta cellulare ai farmaci. I